Heart MRI scar analysis to predict sudden cardiac death after a heart attack
Official title: Comprehensive Cardiac Magnetic Resonance Imaging Evaluation of Myocardial Scar for Predicting Sudden Cardiac Death Post Myocardial Infarction
Run by Beijing Anzhen Hospital · NCT07137936 · Data updated 2026-11-12
This study will see if detailed heart MRI scar pictures can predict out-of-hospital sudden cardiac death in people who have had a heart attack.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Beijing Anzhen Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | December 31, 2036 |
| Study ends | December 31, 2036 |
| Registry record updated | August 22, 2025 |
| Trial ID | NCT07137936 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 who had a heart attack and completed a cardiac MRI at least one month later at Beijing Anzhen Hospital are the intended participants.
✕Probably not a fit
Patients who already have an ICD, have known primary arrhythmia syndromes, established non‑ischemic cardiomyopathy, significant valvular disease, or a life expectancy under one year are unlikely to benefit from the study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This ambispective observational cohort uses cardiac magnetic resonance (CMR) scar imaging, especially late gadolinium enhancement, to link scar characteristics with post‑MI sudden cardiac death. Phase 1 retrospectively enrolled patients treated for MI from 2015–2025 who had CMR at least one month after their MI and collected baseline clinical and imaging data. Phase 2 continues prospective follow-up from 2026–2036 with clinic visits and telephone check‑ins every six months to capture outcomes. The goal is to combine imaging and clinical data into a validated multimodal risk score to better identify high‑risk patients.
Why it matters
Potential benefit: If successful, the work could help clinicians identify post‑MI patients at higher risk of sudden cardiac death so preventive treatments like ICDs can be targeted more accurately.
How similar studies have gone: Previous studies have suggested that CMR scar measures (LGE) relate to arrhythmic risk, but larger validated multimodal risk scores remain limited and need further confirmation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age between 18 and 80 years. 2. Completion of cardiac magnetic resonance (CMR) imaging at Anzhen Hospital during the stable phase (≥1 month) following an acute myocardial infarction (MI). Exclusion Criteria: 1. Prior implantation of an implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) before the index MI. 2. Pre-existing diagnosis of a primary arrhythmia syndrome (e.g., long QT syndrome, Brugada syndrome) before the index MI. 3. Concurrent end-stage disease (e.g., advanced malignancy) directly resulting in an estimated life expectancy of less than one year. 4. History of established non-ischemic cardiomyopathy (e.g., dilated, hypertrophic, or restrictive cardiomyopathy) before the index MI. 5. Significant concomitant valvular heart disease. Status post mechanical heart valve replacement. 6. Patients refuse to be followed up.
Where it's running
-
Beijing Anzhen Hospital
Beijing, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Risk of malignant arrhythmias after acute coronary syndrome
This study tracks how often dangerous heart rhythms occur in adults admitted for ACS and looks for patterns that might predict them.
-
Smartphone AI help for prehospital ECG readings
This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.
-
Optimal timing of staged complete revascularization in STEMI with multivessel disease
This trial tests whether performing staged complete revascularization during the hospital stay or after discharge is best for STEMI patients with multivessel disease.
-
BEAT-SHOCK: Baseline Registry for Acute Cardiogenic Shock at Basel
This registry collects and shares data on adults with cardiogenic shock admitted to University Hospital Basel to help understand how these patients are treated and how they fare.
-
Low-dose IL-2 after heart attack to study tissue-resident regulatory T cells
Researchers are testing whether low-dose interleukin-2 given after a myocardial infarction can boost tissue-resident regulatory T cells to support heart repair.
-
Abbreviated antithrombotic therapy after PCI in AF and MI
This trial tests whether DOAC-only therapy works as well as DOAC plus clopidogrel after PCI in people with atrial fibrillation and a recent heart attack.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.